168 related articles for article (PubMed ID: 30379704)
21. Novel Medical Therapies in Meningiomas.
Danish H; Brastianos P
Adv Exp Med Biol; 2023; 1416():213-223. PubMed ID: 37432630
[TBL] [Abstract][Full Text] [Related]
22. Giant Pediatric Rhabdoid Meningioma Associated with a Germline BAP1 Pathogenic Variation: A Rare Clinical Case.
Ravanpay AC; Barkley A; White-Dzuro GA; Cimino PJ; Gonzalez-Cuyar LF; Lockwood C; Halasz LM; Hisama FM; Ferreira M
World Neurosurg; 2018 Nov; 119():402-415. PubMed ID: 29981911
[TBL] [Abstract][Full Text] [Related]
23. Multiplatform profiling of meningioma provides molecular insight and prioritization of drug targets for rational clinical trial design.
Everson RG; Hashimoto Y; Freeman JL; Hodges TR; Huse J; Zhou S; Xiu J; Spetzler D; Sanai N; Kim L; Kesari S; Brenner A; De Monte F; Heimberger A; Raza SM
J Neurooncol; 2018 Sep; 139(2):469-478. PubMed ID: 29846894
[TBL] [Abstract][Full Text] [Related]
24. Advances in meningioma genetics: novel therapeutic opportunities.
Preusser M; Brastianos PK; Mawrin C
Nat Rev Neurol; 2018 Feb; 14(2):106-115. PubMed ID: 29302064
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological and molecular characteristics of pediatric meningiomas.
Battu S; Kumar A; Pathak P; Purkait S; Dhawan L; Sharma MC; Suri A; Singh M; Sarkar C; Suri V
Neuropathology; 2018 Feb; 38(1):22-33. PubMed ID: 28901666
[TBL] [Abstract][Full Text] [Related]
26. [The Potential of Personalized/Precision Medicine for Meningiomas].
Yamaguchi S; Fujimura M
No Shinkei Geka; 2022 Jan; 50(1):132-140. PubMed ID: 35169093
[TBL] [Abstract][Full Text] [Related]
27. Genomic landscape of intracranial meningiomas.
Bi WL; Abedalthagafi M; Horowitz P; Agarwalla PK; Mei Y; Aizer AA; Brewster R; Dunn GP; Al-Mefty O; Alexander BM; Santagata S; Beroukhim R; Dunn IF
J Neurosurg; 2016 Sep; 125(3):525-35. PubMed ID: 26771848
[TBL] [Abstract][Full Text] [Related]
28. Meningioma: Molecular Updates from the 2021 WHO Classification of CNS Tumors and Imaging Correlates.
Soni N; Ora M; Bathla G; Szekeres D; Desai A; Pillai J; Agarwal A
AJNR Am J Neuroradiol; 2024 Jun; ():. PubMed ID: 38844366
[TBL] [Abstract][Full Text] [Related]
29. Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations.
Reuss DE; Piro RM; Jones DT; Simon M; Ketter R; Kool M; Becker A; Sahm F; Pusch S; Meyer J; Hagenlocher C; Schweizer L; Capper D; Kickingereder P; Mucha J; Koelsche C; Jäger N; Santarius T; Tarpey PS; Stephens PJ; Andrew Futreal P; Wellenreuther R; Kraus J; Lenartz D; Herold-Mende C; Hartmann C; Mawrin C; Giese N; Eils R; Collins VP; König R; Wiestler OD; Pfister SM; von Deimling A
Acta Neuropathol; 2013 Mar; 125(3):351-8. PubMed ID: 23404370
[TBL] [Abstract][Full Text] [Related]
30. Targeted drug therapy for meningiomas.
Norden AD; Drappatz J; Wen PY
Neurosurg Focus; 2007; 23(4):E12. PubMed ID: 17961036
[TBL] [Abstract][Full Text] [Related]
31. Genetic/molecular alterations of meningiomas and the signaling pathways targeted.
Domingues P; González-Tablas M; Otero Á; Pascual D; Ruiz L; Miranda D; Sousa P; Gonçalves JM; Lopes MC; Orfao A; Tabernero MD
Oncotarget; 2015 May; 6(13):10671-88. PubMed ID: 25965831
[TBL] [Abstract][Full Text] [Related]
32. Recent developments in chemotherapy for meningiomas: a review.
Moazzam AA; Wagle N; Zada G
Neurosurg Focus; 2013 Dec; 35(6):E18. PubMed ID: 24289126
[TBL] [Abstract][Full Text] [Related]
33. Molecular pathogenesis of meningiomas.
Perry A; Gutmann DH; Reifenberger G
J Neurooncol; 2004 Nov; 70(2):183-202. PubMed ID: 15674477
[TBL] [Abstract][Full Text] [Related]
34. Meningioma Genomics: Diagnostic, Prognostic, and Therapeutic Applications.
Bi WL; Zhang M; Wu WW; Mei Y; Dunn IF
Front Surg; 2016; 3():40. PubMed ID: 27458586
[TBL] [Abstract][Full Text] [Related]
35. Genomic profile of human meningioma cell lines.
Mei Y; Bi WL; Greenwald NF; Agar NY; Beroukhim R; Dunn GP; Dunn IF
PLoS One; 2017; 12(5):e0178322. PubMed ID: 28552950
[TBL] [Abstract][Full Text] [Related]
36. NF2 gene analysis distinguishes hemangiopericytoma from meningioma.
Joseph JT; Lisle DK; Jacoby LB; Paulus W; Barone R; Cohen ML; Roggendorf WH; Bruner JM; Gusella JF; Louis DN
Am J Pathol; 1995 Nov; 147(5):1450-5. PubMed ID: 7485407
[TBL] [Abstract][Full Text] [Related]
37. Fibroblast growth factor receptor-3 expression in meningiomas with stimulation of proliferation by the phosphoinositide 3 kinase-Akt pathway.
Johnson MD; O'Connell MJ; Pilcher W; Reeder JE
J Neurosurg; 2010 May; 112(5):934-9. PubMed ID: 19698046
[TBL] [Abstract][Full Text] [Related]
38. Genomic Analysis of Posterior Fossa Meningioma Demonstrates Frequent
Williams SR; Juratli TA; Castro BA; Lazaro TT; Gill CM; Nayyar N; Strickland MR; Babinski M; Johnstone SE; Frosch MP; Silverman IM; Ely HA; Kaplan AB; D'Andrea MR; Bihun IV; Hoang K; Batchelor E; Christiansen J; Cahill DP; Barker FG; Brastianos PK
J Neurol Surg B Skull Base; 2019 Dec; 80(6):562-567. PubMed ID: 31750041
[No Abstract] [Full Text] [Related]
39. Durable Control of Metastatic AKT1-Mutant WHO Grade 1 Meningothelial Meningioma by the AKT Inhibitor, AZD5363.
Weller M; Roth P; Sahm F; Burghardt I; Schuknecht B; Rushing EJ; Regli L; Lindemann JP; von Deimling A
J Natl Cancer Inst; 2017 Mar; 109(3):1-4. PubMed ID: 28376212
[TBL] [Abstract][Full Text] [Related]
40. Molecular genetics of meningiomas: from basic research to potential clinical applications.
Simon M; Boström JP; Hartmann C
Neurosurgery; 2007 May; 60(5):787-98; discussion 787-98. PubMed ID: 17460514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
